A detailed history of Schonfeld Strategic Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 6,133 shares of UTHR stock, worth $2.21 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,133
Previous 20,522 70.11%
Holding current value
$2.21 Million
Previous $6.54 Million 66.39%
% of portfolio
0.02%
Previous 0.04%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$311.04 - $363.55 $4.48 Million - $5.23 Million
-14,389 Reduced 70.11%
6,133 $2.2 Million
Q2 2024

Aug 14, 2024

SELL
$228.26 - $319.04 $14.9 Million - $20.8 Million
-65,101 Reduced 76.03%
20,522 $6.54 Million
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $216,661 - $256,496
1,028 Added 1.22%
85,623 $19.7 Million
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $7.63 Million - $9.13 Million
35,523 Added 72.39%
84,595 $18.6 Million
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $2.05 Million - $2.4 Million
9,672 Added 24.55%
49,072 $11.1 Million
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $1.57 Million - $1.78 Million
7,631 Added 24.02%
39,400 $8.7 Million
Q1 2023

May 15, 2023

SELL
$212.99 - $276.17 $10.4 Million - $13.4 Million
-48,649 Reduced 60.5%
31,769 $7.11 Million
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $11.3 Million - $15.4 Million
54,790 Added 213.79%
80,418 $22.4 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $446,243 - $535,953
-2,195 Reduced 7.89%
25,628 $5.37 Million
Q2 2022

Aug 15, 2022

BUY
$174.81 - $241.14 $4.53 Million - $6.25 Million
25,923 Added 1364.37%
27,823 $6.56 Million
Q1 2022

May 16, 2022

SELL
$166.16 - $213.96 $1.88 Million - $2.42 Million
-11,300 Reduced 85.61%
1,900 $341,000
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $2.29 Million - $2.69 Million
-12,430 Reduced 48.5%
13,200 $2.85 Million
Q3 2021

Nov 16, 2021

BUY
$179.86 - $214.88 $3.94 Million - $4.71 Million
21,930 Added 592.7%
25,630 $4.73 Million
Q2 2021

Aug 16, 2021

SELL
$170.47 - $211.93 $1.67 Million - $2.08 Million
-9,800 Reduced 72.59%
3,700 $664,000
Q1 2021

May 17, 2021

BUY
$153.94 - $174.85 $2.08 Million - $2.36 Million
13,500 New
13,500 $2.26 Million
Q3 2020

Nov 16, 2020

SELL
$99.9 - $121.13 $216,882 - $262,973
-2,171 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$92.74 - $125.82 $399,338 - $541,780
-4,306 Reduced 66.48%
2,171 $263,000
Q1 2020

May 15, 2020

BUY
$79.39 - $115.35 $37,313 - $54,214
470 Added 7.82%
6,477 $614,000
Q4 2019

Feb 14, 2020

SELL
$78.31 - $95.34 $5.25 Million - $6.4 Million
-67,096 Reduced 91.78%
6,007 $529,000
Q3 2019

Nov 14, 2019

BUY
$74.85 - $85.99 $4.53 Million - $5.2 Million
60,503 Added 480.18%
73,103 $5.83 Million
Q2 2019

Aug 14, 2019

BUY
$76.06 - $120.81 $958,356 - $1.52 Million
12,600 New
12,600 $984,000
Q3 2018

Nov 14, 2018

SELL
$113.81 - $129.46 $2.04 Million - $2.32 Million
-17,900 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$101.14 - $118.31 $1.81 Million - $2.12 Million
17,900 New
17,900 $2.03 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.